Philip Morris International Inc.(PM)
Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products that are sold in markets outside the United States. The company offers its smoke-free products under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, Parliament HeatSticks, and TEREA brands, as well as the KT&G-licensed brands, Fiit, and Miix. It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands. In addition, the company owns various cigarette brands, such as Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia; and Fortune and Jackpot in the Philippines. The company sells its smoke-free products in 71 markets. Philip Morris International Inc. was incorporated in 1987 and is headquartered in New York, New York.
Latest News & Analysis
Philip Morris International: Smoke-Free Revolution & Investor Impact
Philip Morris International (PMI) is strategically transitioning to smoke-free products like IQOS and ZYN, demonstrating strong growth potential.
Philip Morris (PM): Zyn's Rise, Dividend Concerns, Smoke-Free Future
Philip Morris International is transforming into a smoke-free company, driven by Zyn's popularity. High payout ratio and regulatory challenges pose risks, but growth prospects and defensive characteristics make it an interesting investment.
Philip Morris (PM): Smoke-Free Transformation and ZYN's Rise
PMI is transforming, shifting to smoke-free products like ZYN and IQOS. The company's financials are increasingly driven by these products, aiming for two-thirds of revenue from smoke-free sources by 2030.
Philip Morris (PM): Smoke-Free Strategy, Dividends, and Market Resilience
Philip Morris International navigates a smoke-free future with strategic shifts, dividend focus, and market resilience. A deep dive into PM's financials and strategic moves.
Philip Morris: Intraday Update on Financial and Strategic Developments
Intraday update on Philip Morris, detailing financial performance, strategic shifts, and market dynamics with verified, real-time data.
Philip Morris International: Navigating Smoke-Free Future
Philip Morris International navigates a smoke-free future amidst market volatility, driven by IQOS and ZYN growth, regulatory hurdles, and dividend strategies.
Philip Morris International: A Smoke-Free Future
Philip Morris International navigates a smoke-free future amid shifting investor sentiment and regulatory changes. IQOS and ZYN drive transformation. CAGNY conference insights.
Philip Morris International: Navigating the Smoke-Free Revolution in 2025
Philip Morris International navigates its smoke-free transformation, driven by IQOS and ZYN growth amid evolving regulations and market dynamics.
Philip Morris International: Smoke-Free Revolution Drives Growth in 2025
Explore PMI’s robust Q4 2024 earnings, its groundbreaking shift to smoke-free products, and the regulatory challenges shaping its future.
Philip Morris International: Smoke-Free Future at CAGNY 2025
Philip Morris International focuses on smoke-free future at CAGNY 2025, highlighting IQOS and ZYN growth amid regulatory challenges and market shifts.
PMI's Smoke-Free Future: Q4 Earnings, ZYN Growth & CAGNY 2025 Insights
An in-depth analysis of Philip Morris International’s transformation, Q4 earnings, and breakthrough developments in its smoke-free portfolio.
Philip Morris International Navigates the Smoke-Free Future
In-depth analysis of PM’s Q4 earnings, innovative smoke-free strategies, and a shifting regulatory landscape impacting future growth.
Philip Morris Smoke-Free Transformation: Zyn and IQOS Growth
Philip Morris drives a smoke‐free transformation with strong Q4 earnings and robust growth in Zyn and IQOS amid evolving regulatory challenges.